SVSjoerd M. Verwijs

Sjoerd M. Verwijs

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sjoerd M. Verwijs has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aortic Root Dilation in a Masters Dressage Athlete With Familial TAAD

    by Hiba El Hri, Joelle J.N. Daems, Maarten A. van Diepen, Sjoerd M. Verwijs, Maarten Groenink, Maarten M. Moen, Nick R. Bijsterveld, Harald T. Jørstad

  • Open Access

    Cardiac Ventricular Hinge Point LGE Is Highly Prevalent and Sex-Dependent in ELITE Athletes

    by Sjoerd M. Verwijs, Juliette C. Van Hattum, Joëlle J.N. Daems, S. Matthijs Boekholdt, R. Nils Planken, Maarten Groenink, Adrienne van Randen, Raschel D. van Luijk, Jules L. Nelissen, Maarten H. Moen, et al.

    BACKGROUND: Myocardial late gadolinium enhancement (LGE) using cardiac magnetic resonance imaging has been described in older endurance athletes, particularly at the ventricular hinge point. However, data on young, elite athletes are lacking. We therefore quantified the prevalence of hinge point LGE (HP-LGE) in young elite-level athletes. METHODS: We investigated 309 (40% women; median age 25.1 [21.9–29.5] years) asymptomatic athletes included in the ELITE prospective cohort (Evaluation of Lifetime Participation in Intensive Top-level Sports and Exercise cohort), investigating cardiovascular screenings of elite (national-, international-, Olympic-, or Paralympic-) level athletes, including cardiac magnetic resonance imaging with short-axis cine imaging, LGE, and T1-mapping. RESULTS: A total of 124 (40%) athletes had HP-LGE, with a higher prevalence in men compared with women (47% versus 30%; P =0.004). When indexed for body surface area, athletes with HP-LGE had greater left ventricle end-systolic volumes (53±11 mL/m² versus 51±11 mL/m²; P =0.037), right ventricle end-systolic volumes (56±12 mL/m² versus 53±11 mL/m²; P =0.020), lower left ventricle ejection fraction (55.5±5.0% versus 56.7±4.6%; P =0.035), lower right ventricle ejection fraction (53.9±5.0% versus 55.2±4.4%; P =0.021), and smaller estimated global left ventricle extracellular volumes (24.45±2.52% versus 25.27±2.59%; P =0.015). In multivariable regression analyses, male sex was strongly associated with HP-LGE (odds ratio, 3.07 [95% CI, 1.32–7.32]; P =0.010). CONCLUSIONS: HP-LGE is a common finding in asymptomatic, elite athletes and is strongly associated with sex. Lower left ventricle ejection fraction is moderately associated with HP-LGE. Our study’s HP-LGE prevalence indicates that HP-LGE should be interpreted as a feature of the athlete’s heart.


  • Open Access

    Comparison of 2D Speckle Tracking Echocardiography and Cardiac MRI Feature Tracking for Bi-Atrial Strain Assessment in Elite Athletes

    by Joelle Jn Daems, Maarten A. van Diepen, Juliette C. Van Hattum, Sjoerd Verwijs, Berto J Bouma, H.A.C.M. de Bruin – Bon, Maarten H. Moen, Niek H Prakken, Adrienne van Randen, S. Matthijs Boekholdt, et al.

    Background: Data on Feature-tracking Cardiac Magnetic Resonance imaging (FT-CMR) in athletes is limited, and direct comparison of Speckle Tracking Transthoracic Echocardiography (STE) and FT-CMR-derived bi-atrial strain are lacking. Aim: To compare STE and FT-CMR longitudinal bi-atrial strain in a well-defined cohort of elite athletes and to determine the level of agreement between these modalities. Methods: Agreement between FT-CMR and STE derived bi-atrial strain was assessed in elite athletes from the Evaluation of Lifetime participation in Intensive Top-level sports and Exercise (ELITE) cohort (>16 years; exercise >10h/week; (inter)national or Olympic level). Absolute agreement was evaluated using a two-way mixed-effects model (ICC(3,1)). Results: We included 194 elite athletes (51% women; mean age 30 ±7 years). The interval between TTE and CMR was p < .001), conduit-(0.39 (95% CI: 0.26 – 0.50, p < .001), and contractile strain (0.48 (95% CI: 0.36 – 0.58, p < .001). There was no agreement in right atrial reservoir-(0.02, 95% CI: -0.12 – 0.16, p = .4) and conduit strain (0.09, 95% CI: -0.07 – 0.21, p = .17. There was poor agreement in RA contractile strain (0.218, 95% CI 0.080 – 0.48, p = 0.001). Conclusion: There are important modality-dependent differences in bi-atrial strain in elite athletes. The poor-to-moderate agreement between longitudinal STE and FT-CMR left atrial strain and a lack of agreement in right atrial strain highlights the need to interpret observed values in the context of modality-specific elite athlete reference ranges. Clinicians should avoid direct cross-modality comparison in elite athlete populations.

  • Open Access

    Extreme phenotypes of the female athlete’s heart: a sports-specific cardiac magnetic resonance imaging study

    by Juliette C van Hattum, Maarten A van Diepen, Sjoerd M Verwijs, S Matthijs Boekholdt, Adrienne van Randen, Maarten Groenink, R Nils Planken, Maarten H Moen, Joëlle J N Daems, Niek H J Prakken, et al.

    Aims: Differentiating physiological exercise-induced cardiac remodelling (EICR) from pathology is challenging, especially in female athletes, where studies using state-of-the-art imaging techniques are lacking. We aimed to investigate extreme phenotypes of EICR in female elite athletes using magnetic resonance imaging (MRI). Methods and results: Cross-sectional, multicentre study in female elite athletes using contrast-enhanced cardiac MRI. Left and right ventricle (LV, RV) indices and LV mass (LVM)-to-LV end-diastolic volume (EDV) ratios were investigated, indexed by body surface area (BSA). Cardiac remodelling was determined comparing cardiac MRI metrics to female reference values, stratified by ESC sports classification (endurance, mixed, power/skill). In 173 female elite athletes (median age 25 years, median 18 h training/week, 97% Caucasian), mean LV EDV/BSA and LVM/BSA were 108 ± 13 mL/m2 and 50 ± 10 g/m2, with lower LVM/LV EDV ratios (0.5 ± 0.1) than the general population (0.7 ± 0.1 g/mL; P < 0.001). Most athletes (71%) had isolated LV EDV increases; LVM increases (18%) commonly coincided with LV EDV increases. Compared with the general population (45 ± 7 g/m2), only mixed (48 ± 9 g/m2; P = 0.021) and endurance athletes (53 ± 11 g/m2; P < 0.001) exhibited greater mean LVM with endurance athletes surpassing mixed athletes (P = 0.004). Mixed and endurance showed comparably greater median biventricular EDV compared with power/skill athletes [LV: 109 (103–119) and 111 (101–118) vs. 99 (92–105); RV: 110 (103–118) and 112 (105–124) vs. 101 (95–104) mL/m2; P < 0.001]. Maximum wall thickness > 11 mm was rare (2%). Global T1 time was 968 ± 22 ms; extracellular volume was 25 ± 4%. Conclusion: Female elite athletes, particularly endurance-trained athletes, display EICR marked by increased ventricular volumes, without prominent increases in LVM or wall thickness. Trial Registration Number: NL9328


  • Open Access

    Native T1 mapping times are strongly influenced by elite athlete status

    by Joelle J N Daems, Sjoerd M Verwijs, Maarten A van Diepen, Juliette C van Hattum, Raschel D van Luijk, Maarten H Moen, Jules L Nelissen, Aart J Nederveen, R Nils Planken, Adrienne van Randen, et al.

    Aims: Limited data indicates that athletes’ hearts demonstrate decreased native T1, but this assertion has not been replicated in large cohorts of extreme phenotypes of elite athletes. Therefore, we investigated differences in native T1 between elite athletes and healthy non-athletic controls. Methods and Results: Cross-sectional analysis comparing native T1 between elite athletes (≥16 years; ≥10 h of exercise/week) and age-matched healthy non-athletic controls. All participants underwent cardiovascular magnetic resonance imaging on a 1.5 tesla MRI machine. We included 240 elite athletes [50% women; age 28 years (25–32)] and 80 non-athlete healthy controls [50% women; age 28 years (23–39)]. Elite athletes demonstrated lower native T1 than non-athlete healthy controls (960 ± 21 ms vs. 983 ± 26 ms, P < 0.001), also when stratified by sex (male athletes vs. controls 953 ms ±19 vs. 968 ms ±16, P < 0.001; female athletes vs. controls 968 ms ±20 vs. 999 ms ±25, P < 0.001). Multivariate linear regression identified elite athlete status (β = −13.34, P < 0.001), heart rate (β = 0.6, P < 0.001), average left-ventricular wall thickness (β = −8.28, P < 0.001) and native blood pool T1 (β = 0.09, P < 0.001) as independent determinants of native T1 (adjusted R2 = 51.4%, P < 0.001). Conclusion: Elite athletes have lower native T1 compared with non-athletes, both in women and men. Athlete- and sex-specific reference ranges should be applied when interpreting native T1 in athlete populations, especially in female athletes.


  • Open Access

    The hemodynamic cardiac profiler volume-time curves and related parameters: an MRI validation study

    by Maurits K Konings, Manuella Al Sharkawy, Sjoerd M Verwijs, Adrianus J Bakermans, Martijn Visscher, Charles L Hollenkamp, Denise P Veelo, Harald T Jørstad

    Background. The hemodynamic cardiac profiler (HCP) is a new, non-invasive, operator-independent screening tool that uses six independent electrode pairs on the frontal thoracic skin, and a low-intensity, patient-safe, high-frequency applied alternating current to measure ventricular volume dynamics during the cardiac cycle for producing ventricular volume-time curves (VTCs). Objective. To validate VTCs from HCP against VTCs from MRI in healthy volunteers. Approach. Left- and right-ventricular VTCs were obtained by HCP and MRI in six healthy participants in supine position. Since HCP is not compatible with MRI, HCP measurements were performed within 20 min before and immediately after MRI, without intermittent fluid intake or release by participants. Intraclass correlation coefficients (ICCs) were calculated to validate HCP-VTC against MRI-VTC and to assess repeatability of HCP measurements before and after MRI. Bland–Altman plots were used to assess agreement between relevant HCP- and MRI-VTC-derived parameters. Precision of HCP’s measurement of VTC-derived parameters was determined for each study participant by calculating the coefficients of variation and repeatability coefficients. Main results. Left- and right-ventricular VTC ICCs between HCP and MRI were >0.8 for all study participants, indicating excellent agreement between HCP-VTCs and MRI-VTCs. Mean (range) ICC of HCP right-ventricular VTC versus MRI right-ventricular VTC was 0.94 (0.88–0.99) and seemed to be slightly higher than the mean ICC of HCP left-ventricular VTC versus MRI-VTC (0.91 (0.80–0.96)). The repeatability coefficient for HCP’s measurement of systolic time (tSys) was 45.0 ms at a mean value of 282.9 ± 26.3 ms. Repeatability of biventricular HCP-VTCs was excellent (ICC 0.96 (0.907–0.995)). Significance. Ventricular volume dynamics measured by HCP-VTCs show excellent agreement with VTCs measured by MRI. Since abnormal tSys is a sign of numerous cardiac diseases, the HCP may potentially be used as a diagnostic screening tool.

  • Open Access

    Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports

    by Juliette C van Hattum, Joëlle J N Daems, Sjoerd M Verwijs, Leonoor V Wismans, Maarten A van Diepen, Maarten Groenink, S Matthijs Boekholdt, R Nils Planken, Adrienne van Randen, Alexander Hirsch, et al.

    Objective Longitudinal consequences and potential interactions of COVID-19 and elite-level sports and exercise are unclear. Therefore, we determined the long-term detrimental cardiac effects of the interaction between SARS-CoV-2 infection and the highest level of sports and exercise. Methods This prospective controlled study included elite athletes from the Evaluation of Lifetime participation in Intensive Top-level sports and Exercise cohort. Athletes infected with SARS-CoV-2were offered structured, additional cardiovascular screenings, including cardiovascular MRI (CMR). We compared ventricular volumes and function, late gadolinium enhancement (LGE) and T1 relaxation times, between infected and non-infected elite athletes, and collected follow-up data on cardiac adverse events, ventricular arrhythmia burden and the cessation of sports careers. Results We included 259 elite athletes (mean age 26±5 years; 40% women), of whom 123 were infected (9% cardiovascular symptoms) and 136 were controls. We found no differences in function and volumetric CMR parameters. Four infected athletes (3%) demonstrated LGE (one reversible), compared with none of the controls. During the 26.7 (±5.8) months follow-up, all four athletes resumed elite-level sports, without an increase in ventricular arrhythmias or adverse cardiac remodelling. None of the infected athletes reported new cardiac symptoms or events. The majority (n=118; 96%) still participated in elite-level sports; no sports careers were terminated due to SARS-CoV-2. Conclusions This prospective study demonstrates the safety of resuming elite-level sports after SARS-CoV-2 infection. The medium-term risks associated with SARS-CoV-2 infection and elite-level sports appear low, as the resumption of elite sports did not lead to detrimental cardiac effects or increases in clinical events, even in the four elite athletes with SARS-CoV-2 associated myocardial involvement.


  • Open Access

    ELITE: rationale and design of a longitudinal elite athlete, extreme cardiovascular phenotyping, prospective cohort study

    by Juliette C van Hattum, Sjoerd M Verwijs, S Matthijs Boekholdt, Maarten Groenink, R Nils Planken, Adrienne van Randen, Aart J Nederveen, Maarten H Moen, Cornelis A C M Wijne, Joelle J N Daems, et al.

    Introduction The cardiovascular benefits of physical exercise are well-known. However, vigorous exercise has also been associated with adverse cardiac effects. To improve our understanding of cardiovascular adaptation to exercise versus maladaptation and pathology, the limits of adaptation should be firmly established using state-of-the-art diagnostic modalities. We therefore initiated the Evaluation of Lifetime participation in Intensive Top-level sports and Exercise (ELITE) cohort to investigate the longitudinal (beneficial and pathological) cardiovascular effects of intensive elite sports and exercise. Methods and analysis ELITE is a prospective, multicentre, longitudinal cohort study. Elite athletes, from the age of sixteen, are recruited in The Netherlands. The primary objective is to determine the association between elite sports and exercise-induced cardiac remodelling, cardiac pathology, and health benefits over time. Secondary objectives include determining and identifying genetic profiles of elite athletes, and how these are associated with cardiac indices. ELITE will collect data from consultations, electrocardiography, echocardiography and cardiac magnetic resonance imaging, and training- and injury data. ELITE will also collect blood for biobanking and cardiogenetics. Follow-up will take place at intervals of two to five years, and after the elite athletes’ professional careers have ended. In addition, a subcohort of ELITE has been established to investigate cardiac sequelae following infections associated with myocardial involvement, including SARS-CoV-2. ELITE is a prospective observational study; therefore, analyses will be primarily explorative. Ethics and dissemination This study has been approved by the Medical Ethics Review Board of the Amsterdam University Medical Centers (NL71682.018.19). The results of the study will be disseminated by publication in peer-reviewed journals (Netherlands Trial Register number: NL9328).


  • Open Access

    Beneficial Effects of Cardiomyopathy-Associated Genetic Variants on Physical Performance: A Hypothesis-Generating Scoping Review

    by Sjoerd M. Verwijs, Yigal M. Pinto, Diederik W.D. Kuster, Jolanda van der Velden, Jacqueline Limpens, Juliette C. van Hattum, Saskia N. van der Crabben, Ronald H. Lekanne Deprez, Arthur A.M. Wilde, Harald T. Jørstad

    Background: Genetic variants associated with cardiomyopathies (CMPs) are prevalent in the general population. In young athletes, CMPs account for roughly a quarter of sudden cardiac death, with further unexplained clustering in specific sports. Consequently, most CMPs form a contraindication for competitive sports. We hypothesized that genetic variants might (paradoxically) improve physical performance early in life while impairing cardiac function later in life. Methods: Systematic PubMed search was done to investigate whether genetic variants in genes associated with CMPs could be related to beneficial performance phenotypes. Summary: In a limited number of studies (n = 6), 2,860 individuals/subjects with genetic variants were able to outperform those without said variants, as measured by running speed (∼38 m/min in heterozygous [HET] mice, n = 6, vs. ∼32 m/min in wild type [WT] mice, n = 7, p = 0.004) and distance (966 ± 169 km HET mice vs. 561 ± 144 km WT mice, p = 0.0035, n = 10), elite athlete status in endurance athletes (n = 1,672, p = 1.43 × 10−8), maximal oxygen uptake in elite athletes (absolute difference not provided, n = 32, p = 0.005), maximal oxygen uptake in unrelated individuals (n = 473, p = 0.0025), personal records in highly trained marathon runners (2:26:28 ± 0:06:23 min HET, n = 32, vs. 2:28:53 ± 0:05:50 min without polymorphism, n = 108, p = 0.020), and peripheral muscle force contraction in patients following a cardiac rehabilitation program (absolute values not provided, n = 260). Key Message: Beneficial effects in genetic variants associated with CMPs could hypothetically play a role in the selection of young athletes, consequently explaining the prevalence of such genetic variants in athletes and the general population.